Prophylactic high-dose vitamin D during enfortumab vedotin rechallenge attenuates toxic erythema of chemotherapy-like eruption: a three-patient case series
Prophylactic high-dose vitamin D during enfortumab vedotin rechallenge attenuates toxic erythema of chemotherapy-like eruption: a three-patient case series. // JAAD Case Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2352512626006776?dgcid=rss_sd_all
Prophylactic high-dose vitamin D during enfortumab vedotin rechallenge attenuates toxic erythema of chemotherapy-like eruption: a three-patient case series. JAAD Case Reports. https://www.sciencedirect.com/science/article/pii/S2352512626006776?dgcid=rss_sd_all
“Prophylactic high-dose vitamin D during enfortumab vedotin rechallenge attenuates toxic erythema of chemotherapy-like eruption: a three-patient case series.” JAAD Case Reports.
@article{article50626,
title = {Prophylactic high-dose vitamin D during enfortumab vedotin rechallenge attenuates toxic erythema of chemotherapy-like eruption: a three-patient case series},
journal = {JAAD Case Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2352512626006776?dgcid=rss_sd_all}
}